EP2928467A4 - Methods for restoration of histamine balance - Google Patents

Methods for restoration of histamine balance

Info

Publication number
EP2928467A4
EP2928467A4 EP13859813.1A EP13859813A EP2928467A4 EP 2928467 A4 EP2928467 A4 EP 2928467A4 EP 13859813 A EP13859813 A EP 13859813A EP 2928467 A4 EP2928467 A4 EP 2928467A4
Authority
EP
European Patent Office
Prior art keywords
restoration
methods
histamine balance
histamine
balance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP13859813.1A
Other languages
German (de)
French (fr)
Other versions
EP2928467A1 (en
Inventor
Cristian Arnou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biohealthonomics Inc
Original Assignee
Biohealthonomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohealthonomics Inc filed Critical Biohealthonomics Inc
Publication of EP2928467A1 publication Critical patent/EP2928467A1/en
Publication of EP2928467A4 publication Critical patent/EP2928467A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EP13859813.1A 2012-12-05 2013-06-18 Methods for restoration of histamine balance Withdrawn EP2928467A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261733630P 2012-12-05 2012-12-05
PCT/US2013/046420 WO2014088641A1 (en) 2012-12-05 2013-06-18 Methods for restoration of histamine balance

Publications (2)

Publication Number Publication Date
EP2928467A1 EP2928467A1 (en) 2015-10-14
EP2928467A4 true EP2928467A4 (en) 2016-05-25

Family

ID=50883850

Family Applications (1)

Application Number Title Priority Date Filing Date
EP13859813.1A Withdrawn EP2928467A4 (en) 2012-12-05 2013-06-18 Methods for restoration of histamine balance

Country Status (5)

Country Link
EP (1) EP2928467A4 (en)
JP (1) JP6395720B2 (en)
BR (1) BR112015012712A2 (en)
CA (1) CA2893438A1 (en)
WO (1) WO2014088641A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4544629A (en) * 1982-11-19 1985-10-01 Minnesota Mining And Manufacturing Company Receptor-based histamine assay
US6071942A (en) * 1996-05-14 2000-06-06 Maxim Pharmaceuticals, Inc. Elevation of circulating blood histamine levels
US6432986B2 (en) * 1997-07-21 2002-08-13 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
US20030143195A1 (en) * 2002-01-30 2003-07-31 Pinsker Judy Senior Use of histamine as a drug delivery enhancing compound for use in transmucosal or transdermal delivery

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
CA2893438A1 (en) 2014-06-12
WO2014088641A1 (en) 2014-06-12
JP2016505562A (en) 2016-02-25
JP6395720B2 (en) 2018-09-26
EP2928467A1 (en) 2015-10-14
BR112015012712A2 (en) 2017-07-11

Similar Documents

Publication Publication Date Title
GB2504593B (en) Method of forming silicon
PL2825719T3 (en) Method of well operation
ZA201405746B (en) Rafamycin analogs and methods for making same
EP2836221A4 (en) Method of using cyclodextrin
GB2507645B (en) Collet
ZA201406082B (en) Use of ccr3-inhibitors
EP2917314A4 (en) Composition of oligomerate
HK1201532A1 (en) Method for preparation of medetomidine
HK1209422A1 (en) Fbxo3 inhibitors fbxo3
EP2852403A4 (en) Methods for modification of tissues
ZA201503034B (en) Method of weight management
EP2881113A4 (en) New application of pogostone
PL2809816T3 (en) Expression method
IL219244A0 (en) Splitting of user-lists
PL2888228T3 (en) Inhibitors of cd40-traf6 interaction
EP2892529A4 (en) Uses of (-)-perhexiline
GB201218081D0 (en) Prosthesis
ZA201502350B (en) Solid form of hihydro-pyrido-oxazine derivative
GB201215942D0 (en) Method of treatent
EP2928467A4 (en) Methods for restoration of histamine balance
EP2887938A4 (en) Methods of preparing tecovirimat
FI3473276T3 (en) Techniques for treatment of abscesses
ZA201503833B (en) Method of hemoglobin-f determination
GB201506161D0 (en) Maxu stairs
GB201212279D0 (en) Method of construction

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150703

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20160428

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/417 20060101AFI20160421BHEP

Ipc: A61K 31/66 20060101ALI20160421BHEP

Ipc: A61P 25/06 20060101ALI20160421BHEP

17Q First examination report despatched

Effective date: 20180214

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20180825